Abstract 16, 16 Dimethyl prostaglandin E2 (dmPGE2), a known cytoprotective agent, was examined for its ability to alter the course of fulminant hepatitis in an experimental model of fulmnnt viral hepatitis, murine hepatitis virus type 3 (MHV-3). Fully susceptible BALB/cJ mice, infected with 100 50% lethal doses (LD50) of MHV-3 developed histologic and biochemical evidence of fulminant hepatitis, as evidenced by massive hepatic necrosis with hypoglycemia, metabolic acidosis, and a markedly elevated serum alanine aminotransferase (ALT) (mean, 1,402±619 lU/liter). In contrast, animals treated with dmPGE2 either before or after infection (up to 48 h) demonstrated a marked reduction in both histologic and biochemical evidence of liver damage as characterized by normal blood glucose, total C02, and ALT determinations (mean ALT, 63±40 lU/liter). Treatment of infected mice with PGFu demonstrated no cytoprotective effects. High titers of infectious virus were recovered from the livers of both dmPGE2-treated and -untreated animals throughout the course of infection.
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In a parallel in vitro study, dmPGE2 (10-4-10-1 M) demonstrated a similar cytoprotective effect on monolayers of isolated cultured hepatocytes from fully susceptible BALB/cJ mice infected at a multiplicity of infection of 0.1, 1.0, and 10.0.
In addition, splenic macrophages recovered from infected and untreated BALB/cJ mice demonstrated a marked augmentation in procoagulant activity (PCA) from a basal 10±5 mU/10' splenic macrophages to a maximum of 615±102 mU/106 splenic macrophages, whereas no increase in macrophage PCA was detected in infected animals treated with dmPGE2. These results suggest that dmPGE2, without detectably altering viral replication or infectivity in vivo, confers a marked cytoprotective effect on hepatocytes both in vivo and in vitro, and prevents the induction of macrophage PCA in vivo in fully susceptible BALB/cJ mice after murine hepatitis virus type 3 infection.
Introduction
Prostaglandin is a generic term describing a family ofbioactive lipids derived from arachidonic acid via the cyclooxygenase pathway. The biological activities attributed to these com-pounds are both varied and heterogeneous. A number of investigators have demonstrated the cytoprotective effects of prostaglandins, in particular 16, 16 dimethyl prostaglandin E2 (dmPGE2),' in gastric mucosa (1) , in the liver (2) , and in the kidney (3) in response to a variety of toxins and other noxious stimuli. However, the cytoprotective role of analogues of prostaglandins of the E series has not been paralleled by PGF2, analogues (4, 5). In addition, prostaglandins have been shown to have varied effects on smooth muscle, particularly changes in the tone of blood vessel musculature (6). Furthermore, it is generally accepted that they exert a predominantly suppressive effect on the immune system, the mechanism of which is poorly understood (7) . It has been demonstrated that many macrophage activation parameters are modulated by exogenous PGE2 (8, 9) . More recently both endogenous and exogenous arachidonic acid metabolites (PGE2 and PGI2) have been shown to affect the expression of class II histocompatibility molecules by murine macrophages (10) . Reports (14) .
MHV-3 is a member of the coronavirus family; it contains single-stranded RNA of positive polarity and produces a strain-dependent spectrum of liver disease in inbred strains of mice. Mice ofthe A strain are fully resistant, whereas BALB/cJ mice are fully susceptible to acute infection and die of fulminant hepatitis. Although the pathogenic mechanism is not clear, the virus is known to exert a direct cytopathic in vitro effect on hepatocytes isolated from both susceptible and resistant animals (15). In addition, immunologic factors are important determinants of susceptibility to MHV-3 infection (16) and resistance in vivo requires at least three subpopulations of immune cells (17) (18) (19) (20) Prostaglandins. dmPGE2 and dmPGF2, were kindly provided by the Upjohn Co., Kalamazoo, MI, and were reconstituted in absolute ethanol to a stock concentration of 10 mg/ml. Dilutions were then carried out using a 0.1-M phosphate buffer (pH 7.4) and the freshly prepared solution was injected intraperitoneally. Vehicle controls were prepared using an identical amount of absolute ethanol diluted in 0.1 M phosphate buffer (pH 7.4), and this resulted in an equivalent final concentration of ethanol. A dose titration was performed to establish the highest non-toxic dose of both prostaglandins. A dose > 2 gg/kg body weight of dmPGF2, or 10 Mg/kg dmPGE2 resulted in a dose-dependent incidence ofmortality, whereas a dose between 2 and 10 Mg/kg of dmPGE2 resulted in a dose-dependent incidence of diarrhea and dehydration (weight loss, elevated blood urea nitrogen). The selected dosage of 2 Mg/kg body weight for both agents was used in all subsequent experiments, and this resulted in no detectable diarrhea and no mortality in control animals (i.e., prostaglandin alone).
Mice In our initial experiments, the animals were pretreated with prostaglandin or vehicle 30 min before infection and 30 min after infection.
They were then treated every 2 h for 24 h and every 8 h thereafter. In subsequent experiments, pretreatment with prostaglandin was omitted and the aforementioned protocol was initiated at 30 min, 24 or 48 h after infection.
Mice were killed at 24, 48, 72, and 96 h after infection, blood was obtained by axillary bleeding, and tissues were studied for viral titers and histology.
Biochemistry. The sera from all animals were analyzed quantitatively for serum alanine aminotransferase (ALT) using a Worthington Statzyme GPT kit obtained from Cooper Biomedical, Inc., Malvern, PA, as previously described (26). Blood glucose, electrolytes, blood urea nitrogen, creatinine, amylase, bilirubin, calcium, and phosphorus were analyzed on an Ektachem 700 analyzer in the Department of Biochemistry at Mount Sinai Hospital, Toronto, Canada.
Histological examination and quantitation ofnecrosis. Samples of liver were sliced into 1 X 0.2-cm blocks and were fixed by immersion into 10% formalin (Fischer Scientific Co., Fairlawn, NJ) in 0.1 M phosphate buffer, pH 7.4. After fixation, the tissues were dehydrated in graded alcohols and xylene, were embedded in paraffin, and a total of three 4-Mum sections were cut and stained with Harris' hematoxylin for 4 min, and were then counterstained with eosin Y for 30 s. The sections were then washed with distilled water, dehydrated in graded alcohols and xylene, and were mounted with Permount. To quantitate the effect of the prostaglandins on liver histology, a digitalized image analysis system HP-88 (Hewlett-Packard Co. Ltd., Mississauga, Canada) with customized software was used. This constitutes a modification of a technique described previously (27) . The areas of necrosis were encircled, as well as the entire section, yielding a percentage figure representing the proportion of diseased liver present in that particular section. Three sections from different parts of the liver were assayed in this fashion for each animal (n = 10/group), and the mean±standard deviation calculated.
Viral titers. Frozen liver tissue (-70'C) was homogenized in DME supplemented with 2% FCS and 4 mM glutamine as a 10% homogenate at 40C. Viral titers were then determined on monolayers of L2 cells in a standard plaque assay (21).
Infectivity assay. Susceptibility of mice to lethal infection with MHV-3 was determined. Liver homogenates were assayed for viral titers as described in the preceding section, appropriately diluted, and then injected intraperitoneally. After infection, the animals were observed for 10 days and mortality data obtained. A total of 84 BALB/cJ mice were infected intraperitoneally in groups of seven with 0.1, 1.0, 10, or 1,000 PFU of MHV-3, derived from one of three sources: stock MHV-3; liver homogenates of infected and untreated animals; liver homogenates of infected but dmPGE2-treated animals.
Isolation of spleen cells. Cells were isolated from the spleens of BALB/cJ mice and resuspended in DME. Mononuclear cells were isolated over Ficoll-Hypaque (Pharmacia Co. Ltd., Montreal, Canada) (density: 1.034 g/ml) gradients by centrifugation at 220C at 2,200 g for 12 min. Cells at the interface were harvested, yielding a cell population consisting of> 98% mononuclear cells by cytologic examination using Giemsa stain. Cells were washed twice and resuspended in DME at a concentration of 2 X 106 mononuclear cells per milliliter.
PCA. Samples of cells, after three cycles of freeze thawing and sonication were assayed for the capacity to shorten the spontaneous clotting time of normal citrated human plasma in a one-stage clotting assay (28). To 0.1 ml ofcellular homogenate at 41C, 0.1 ml of citrated normal human platelet-poor plasma was added, followed by 0.1 ml of 25 mM CaCl2 to start the reaction. The time for the appearance of a fibrin gel was recorded. Clotting times were converted to units of PCA by comparison to a rabbit brain thromboplastin standard (Dade Div., American Hospital Supply, Miami, FL) where 36 mg dry weight per milliliter were assigned a value of 100,000 mU PCA. The assay was utilized over the range of 1 to 100,000 mU or 102 to 108 cells, this range being linear with normal plasma substrate. Media and buffers were all without activity.
Endotoxin contamination. DME, virus preparations, prostaglandins, and spleen cell preparations were assayed for endotoxin contamination by standard limulus assay (E. toxate; Sigma Chemical Co.) and contained < 0.1 ng/ml of endotoxin, which constitutes lower limits of this test (29, 30 (Fig. 1) . In MHV-3-infected mice, there was a marked hypoglycemia and metabolic acidosis consistent with hepatic failure. In contrast, no abnormalities in blood glucose or TCO2 were seen in dmPGE2-treated and infected animals ( Table I) . Similar results were obtained when mice were infected with increasing concentrations of MHV-3 (to 1,000 PFU) (data not shown). (Fig. 4) . A similar protective effect was seen when initiation of treatment with dmPGE2 was delayed for 24 or 48 h, but not 72 h (Fig. 5) . In contrast to the infected, dmPGE2-treated mice, those treated with dmPGF21, demonstrated as marked liver disease as untreated, or vehicle-treated infected animals. (Fig. 4) . Treatment with dmPGE2 or dmPGF2, alone resulted in no detectable liver disease.
Initially, the protective effect of dmPGE2 was demonstrated using an inoculum of 10 (Fig. 6) rophages) or infected and dmPGE2-treated mice (785±95 mU/106 macrophages) was comparable with that from mice infected with stock MHV-3 (730±100 mU/106 macrophages).
Survival data. There was no difference in survival between infected animals, and those infected and treated with either dmPGE2, dmPGF2a, or vehicle. All animals died within 5 d after infection whether or not they received prostaglandin.
Isolated hepatocyte cultures. Hepatocyte monolayers were established. In the infected (MHV-3) but not treated (dmPGE2) cell cultures, cytopathic effect was observed by 18 h, as demonstrated by the formation of syncitia representing the fusion of hepatocytes with degradation of the outer cell membrane. By 48 h, syncitial formation was complete, and cell lysis occurred with the destruction of the hepatocyte monolayer (Fig. 9) . In contrast, in the infected cells treated with dmPGE2, there was a marked reduction in cytopathic effect, although occasional syncitia were still evident. Optimal cytoprotection was achieved at l0-4 M dmPGE2 (Fig. 9) . Discussion from liver homogenates of both dmPGE2-treated and -untreated animals, and these persisted until the death of the animals (Fig. 7) . There was no statistically significant difference between treated and untreated groups (P > 0.05).
Infectivity assay. Using the method of Reed and Muench (32), an LDm for BALB/cJ of < 1-5 PFU was established for MHV-3 from all three sources assayed. MHV-3 recovered from infected and dmPGE2-treated animals was as pathogenic as stock MHV-3 or virus recovered from infected and untreated mice, and thus resulted in equivalent mortality. (Fig.  8) . Furthermore, maximal PCA from BALB/cJ mice that were infected with MHV-3 derived from liver homogenates of either infected and dmPGE2-untreated (745±115 mU/106 mac- The lack of a detectable protective effect by dmPGF2a in our studies is consistent with previous reports by others (4, 5) , in which this analogue was unable to confer a protective effect similar to that of dmPGE2 and points to the heterogenous properties of these agents. The cytoprotective effect of dmPGE2 on hepatocyte cultures infected with MHV-3 in vitro suggests that dmPGE2 acts, at least in part, directly at the level of the hepatocyte. Although others have reported that certain prostaglandins alter the fluidity of the lipid bilayer of mouse liver membranes as evidenced by changes in membrane viscosity using fluorescence probes (34) , it is unlikely that this effect of PGE2 interferes with either budding of the virus or expression ofa viral receptor as virus was isolated in equal titers from the livers of both dmPGE2-treated and -untreated mice.
Our data suggests that in addition to acting directly at the hepatocyte level, dmPGE2 may also influence the immune response to MHV-3. Sitrin et al. have demonstrated that the addition of PGE2 or PGE, reverses the suppressive action of indomethacin on PCA after stimulation in vitro by bacterial lipopolysaccharide of rabbit alveolar macrophages (35) . They concluded from these studies that prostaglandins of the E series were required for the augmentation of PCA in this system. In contrast, Edgington et al. (36) Our laboratory has previously shown a deleterious effect of MHV-3 on the microcirculation ofthe liver early in the course of infection (22). This is characterized by granular blood flow, sinusoidal microthrombi, distortion of sinusoids by edematous hepatocytes, and the formation, as early as 12 h after infection, of localized avascular foci of necrosis with fibrin deposition. It has been proposed that these effects are secondary to induction of PCA, which results in alterations in the immune coagulation system. Prostaglandins, particularly those of the E and I types, are known to relax circular smooth muscle of various animal species and lead to vasodilatation (6). Thus, the observed cytoprotective effect of dmPGE2 could be the result of improved microcirculatory flow in the livers of treated mice.
Despite the remarkable hepatic cytoprotection afforded by dmPGE2 in our murine system, mortality was unchanged. The failure of dmPGE2 treatment to prolong survival, despite the absence biochemically and histologically of liver disease, demonstrates the complexity of fulminant systemic viral infection. It is known that members of the mouse hepatitis virus family are not exclusively hepatotropic (45, 46) , and infections with these viruses result in demyelinating neurological lesions which have been well characterized. However, this group of viruses form a spectrum within which MHV-3 represents one of the more hepatovirulent (47) . Nevertheless, it has been established that MHV-3 replicates in other organs including brain, kidney, pancreas, spleen, lung, and lymph nodes (48) . Hence, mortality that occurs during fulminant viral hepatitis may be attributed to infection of other organ systems. The absence of hypoglycemia and of a metabolic acidosis in infected animals treated with dmPGE2 precludes the possibility of disruption of hepatic synthesis and metabolism.
We have shown in this report a hepatic cytoprotective effect both in vivo and in vitro by the synthetic dmPGE2 in a murine model of fulminant hepatitis. The ability of dmPGE2 to prevent both the induction of PCA and the development of liver disease in susceptible animals is similar to the course of MHV-3 infection in resistant A/J mice in which viral replication proceeds in the absence of induction of PCA and liver injury (21, 49) . This constitutes additional evidence for a role of PCA in the pathogenesis of MHV-3 infection. Further studies are ongoing in our laboratory in an attempt to elucidate the mechanism of hepatic protection of dmPGE2 in fulminant murine viral hepatitis infection.
